申请人:Bristol-Myers Squibb Company
公开号:US05972961A1
公开(公告)日:1999-10-26
The present invention provides novel 4-aryl-3-aminoquinolin-2-one derivatives having the general formula ##STR1## wherein R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined herein, or a non-toxic pharmaceutically acceptable salt thereof which are modulators of the large conductance calcium-activated K.sup.+ channels and are useful in the treatment of disorders which are responsive to the opening of the potassium channels.
本发明提供了一种新颖的4-芳基-3-氨基喹啉-2-酮衍生物,其具有通式##STR1##其中R、R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5和R.sup.6如本文所定义,或其非毒性药学上可接受的盐,它们是大电导钙激活的K.sup.+通道调节剂,并且可用于治疗对钾通道开放有反应的疾病。